November 01, 2025
According to market projections, the oncology drugs sector is expected to grow from USD 204.39 billion in 2024 to USD 360.79 billion by 2034, reflecting a CAGR of 6.29%. The oncology drugs market is growing due to the increasing incidence of cancer, ...
November 01, 2025
According to market projections, the U.S. oncology drugs sector is expected to grow from USD 95.69 billion in 2024 to USD 246.85 billion by 2034, reflecting a CAGR of 9.94%. The extensive research, scientific innovations, and the market penetration...
November 01, 2025
According to market projections, the immuno-oncology drugs sector is expected to grow from USD 94 billion in 2024 to USD 421.27 billion by 2034, reflecting a CAGR of 16.34%. Across the globe, a rising number of cancer patients is associated with the ...
November 01, 2025
According to market projections, the global biopharmaceutical contract manufacturing market, valued at USD 40.14 billion in 2024, is anticipated to reach USD 115.65 billion by 2034, growing at a CAGR of 11.14% over the next decade.The biopharmaceut...
October 28, 2025
The advanced liver cancer treatment drugs market is expanding due to increased adoption of systemic therapies over traditional chemotherapy and growing approvals of immuno-oncology agents. North America led the market due to the presence of a well-de...
November 01, 2025
According to market projections, the global oncology API market, valued at USD 41.79 billion in 2024, is anticipated to reach USD 69.55 billion by 2034, growing at a CAGR of 5.24% over the next decade. The rising prevalence of cancer and the growing ...
October 16, 2025
Market insights predict, the AI in oncology industry is expected to grow from USD 1.95 billion in 2024 to USD 25.02 billion by 2034, driven by a CAGR of 29.36%. The AI in oncology market is growing due to this technology transforming cancer imaging, ...
October 16, 2025
The oncology biomarker market is valued at USD 38.62 billion in 2025 and is projected to reach USD 113.54 billion by 2034, growing at a CAGR of 12.73%. The report covers market segments by biomarker type, including genomic (35% share in 2024) and pro...
November 14, 2025
Based on market forecasts, the DNA methylation sector will expand from USD 2.05 billion in 2025 to USD 7.36 billion by 2035, experiencing a CAGR of 13.64%. The emerging trend of genomic imprinting and gene expression regulation drives the importance ...
October 17, 2025
The global Pre-Dx oncology market is growing with rising cancer incidence and advanced early detection technologies. North America led with 45% share in 2024, while Asia Pacific is fastest-growing. Liquid biopsy tests accounted for 40% revenue, MCED ...
November 17, 2025
According to market projections, the radiation oncology sector is expected to grow from USD 12.45 billion in 2025 to USD 36.78 billion by 2035, reflecting a CAGR of 11.44%. The rising prevalence of cancer and technological advancements drive the glob...
November 24, 2025
Market insights predict the APAC clinical trials industry will increase from USD 18.87 billion in 2025 to USD 41.33 billion by 2035, achieving a CAGR of 7.16%. The market is growing due to the increasing demand for new and effective therapies and ris...
December 19, 2025
The precision oncology market size is calculated at $132.87 billion in 2025 is to hit $341.51 billion by 2035. COTA, Inc. and Guardant Health collaborated to advance biomarker-based cancer therapies. Caris Life Sciences added UVA Cancer Center to its...
October 22, 2025
Projections indicate that, GMP peptides industry is projected to rise from USD 1.3 billion in 2024 to USD 2.9 billion by 2034, reflecting a CAGR of 8.35% over the next decade. The growing demand for peptide drugs and technological advancements drives...
October 07, 2025
According to market projections, the Europe pharmaceutical market, valued at USD 467.59 billion in 2024, is anticipated to reach USD 820.05 billion by 2034, growing at a CAGR of 5.78% over the next decade. The Europe pharmaceutical market is expandin...
October 28, 2025
Based on market forecasts, the U.S. oncology sector will expand from USD 72.79 billion in 2024 to USD 211.78 billion by 2034, experiencing a CAGR of 11.75%. The West region led the market due to the vital contribution of California in the oncology ...
October 01, 2025
According to market projections, the peptide therapeutics sector is expected to grow from USD 49.17 billion in 2024 to USD 81.5 billion by 2034, reflecting a CAGR of 5.35%. The peptide therapeutics market is growing due to rising demand for personali...
October 16, 2025
According to market projections, the oncology devices sector is expected to grow from USD 150.35 billion in 2024 to USD 776.3 billion by 2034, reflecting a CAGR of 17.84%. The increasing prevalence and awareness of cancer and the shift towards person...
November 01, 2025
According to market projections, the oncology drug discovery sector is growing due to the rising prevalence of cancer and increasing demand for targeted, personalized therapies. Advances in genomics and biotechnology are accelerating the development ...
November 01, 2025
Market insights predict, the brachytherapy industry is expected to grow from USD 1.04 billion in 2024 to USD 2.10 billion by 2034, driven by a CAGR of 7.27%. The market is growing due to the increasing prevalence and rising demand for targeted, minim...
November 01, 2025
Forecasts suggest that the non-oncology precision medicine market will expand from USD 83.87 billion in 2024 to USD 193.16 billion by 2034, with a CAGR of 8.7% during this period. Non-Oncology Precision Medicine tailors treatments to individual patie...
October 16, 2025
The veterinary oncology market reached USD 1.58 billion in 2024 and is set to grow to USD 1.77 billion in 2025, reaching USD 4.86 billion by 2034 at a CAGR of 12.14%. The report covers market segmentation by animal, therapy, and cancer type, regional...
December 23, 2025
Market insights predict, the targeted therapy industry is expected to grow from USD 80.18 billion in 2024 to USD 155.82 billion by 2034, driven by a CAGR of 6.87%. In 2024, North America led the targeted therapy market (32%), with Asia Pacific set fo...
November 01, 2025
Based on market forecasts, the U.S. oncology molecular diagnostics sector will expand from USD 810 million in 2024 to USD 2570.17 million by 2034, experiencing a CAGR of 12.24%. In 2024, breast cancer dominated the market, while liver cancer is expec...
October 15, 2025
Market insights predict, the oncology automation industry is expected to grow from USD 2.82 billion in 2024 to USD 7.77 billion by 2034, driven by a CAGR of 10.68%. The oncology automation market is growing due to rising cases of cancer, leading to a...
December 23, 2025
According to market projections, the oncology NGS sector is expected to grow from USD 508.95 million in 2024 to USD 2,193.49 million by 2034, reflecting a CAGR of 15.73%. The demand for NGS in oncology is high due to growing cases of cancer and R&...
November 01, 2025
Market insights predict the global clinical trial imaging industry will increase from USD 2.41 billion in 2024 to USD 5.58 billion by 2034, achieving a CAGR of 8.8%. The market is growing due to the increasing adoption of advanced imaging technologie...
November 01, 2025
According to market projections, the oncology clinical trial sector is expected to grow from USD 13.64 billion in 2024 to USD 22.85 billion by 2034, reflecting a CAGR of 5.30%. Growing patient awareness, better diagnostic tools have increased the dem...
November 28, 2025
Forecasts suggest that the oncology molecular diagnostics market will expand from USD 3.48 billion in 2025 to USD 10.93 billion by 2035, with a CAGR of 12.13% during this period. In 2024, North America led the global oncology molecular diagnostics ma...
December 22, 2025
Market insights predict the global hemato-oncology testing industry will increase from USD 3.56 billion in 2024 to USD 11.47 billion by 2034, achieving a CAGR of 12.4%. In 2023, service offerings led the market with a 58% share. Leukemia remained the...
December 24, 2025
Projections indicate that, surgical microscope industry is projected to rise from USD 1.37 billion in 2024 to USD 3.87 billion by 2034, reflecting a CAGR of 10.97% over the next decade.Investments in healthcare infrastructure, especially in emergin...
November 01, 2025
The multiple modalities in oncology market is expanding due to increasing tumor heterogeneity as well as growing treatment approaches. North America led the market due to the presence of the advanced healthcare sector....
November 01, 2025
The microfluidics in oncology market is growing due to this system offering more sensitive and precise detection of cancer biomarkers and therapeutic approaches than traditional assays....
November 01, 2025
According to forecasts, the global oncology companion diagnostic market will grow from USD 5.24 billion in 2024 to USD 12.07 billion by 2034, with an expected CAGR of 8.73%. Across the world, North America showed dominance due to its possession of a ...
November 20, 2025
Based on market forecasts, the global oncology market, projected at USD 225.05 billion in 2024, is expected to reach USD 600.97 billion by 2034, growing at a CAGR of 11.54% over the forecast period.The oncology market is expanding due to rising can...
November 01, 2025
The rising prevalence of cancer and technological advancements are the major growth factors of the market. North America dominated the global market, owing to favorable government initiatives and increasing investments....
November 01, 2025
Rising advantages of AI and ML in the world are reducing timelines, cost-effective approaches in drug discovery and clinical trials are driving the global market. North America was dominant in the market due to technological advancements by using AI ...
November 01, 2025
The rapid genomic diagnostics market is rising due to the growing focus on rare disease & genetic disease diagnostics. North America’s dominance is attributed to technological advancements in bioinformatics....
November 01, 2025
Based on market forecasts, the global tele-oncology market, projected at USD 4.74 billion in 2024, is expected to reach USD 20.48 billion by 2034, growing at a CAGR of 15.76% over the forecast period. A sure sign of the adoption of advanced he...
November 01, 2025
Market insights predict the global radionuclide drug conjugates (RDC) industry will increase from USD 3.24 billion in 2024 to USD 8.87 billion by 2034, achieving a CAGR of 10.54%. The global radionuclide drug conjugates (RDC) market is growing stro...
November 01, 2025
Based on market forecasts, the monoclonal antibodies therapeutics sector will expand from USD 265.17 billion in 2024 to USD 1057.91 billion by 2034, experiencing a CAGR of 14.84%. In 2024, North America led the monoclonal antibody therapeutics market...
November 01, 2025
Based on market forecasts, the global radiotherapy market, projected at USD 7.88 billion in 2024, is expected to reach USD 15.63 billion by 2034, growing at a CAGR of 7.09% over the forecast period. The market is expanding due to the increasing glo...
November 01, 2025
The U.S. oncology pharmaceutical market is expanding due to increasing cancer awareness as well as growing cancer drug development. ...
November 01, 2025
Based on market forecasts, the global GCC compounding pharmacy market, projected at USD 16.39 million in 2024, is expected to reach USD 40.26 million by 2034, growing at a CAGR of 9.27% over the forecast period.The growing demand for personalized med...
November 01, 2025
Based on market forecasts, the global clinical trial services market, projected at USD 60.7 billion in 2024, is expected to reach USD 141.85 billion by 2034, growing at a CAGR of 8.85% over the forecast period. The clinical trial services market is...
November 01, 2025
Market insights predict, the humanized mouse and rat model industry is expected to grow from USD 257.2 million in 2024 to USD 563.03 million by 2034, driven by a CAGR of 8.15%. The humanized mouse and rat model market is increasing due to growing dem...
November 01, 2025
Market insights predict, the oncology biosimilars industry is expected to grow from USD 6.7 billion in 2024 to USD 36.23 billion by 2034, driven by a CAGR of 18.47%. The oncology biosimilars market is witnessing rapid growth, offering similar and c...
November 01, 2025
According to market projections, the pain management drugs sector is expected to grow from USD 84.1 billion in 2024 to USD 126.17 billion by 2034, reflecting a CAGR of 4.14%. The rising prevalence of chronic pain and growing research and development ...
October 29, 2025
According to market projections, the nucleic acid drugs sector is expected to grow from USD 47.59 million in 2024 to USD 286.13 million by 2034, reflecting a CAGR of 19.84%. The nucleic acid drugs market is expanding due to advances in delivery techn...
November 12, 2025
Based on market forecasts, the global ophthalmology drugs market, projected at USD 45.52 billion in 2025, is expected to reach USD 76.51 billion by 2035, growing at a CAGR of 5.33% over the forecast period. The ophthalmology drugs market is growing...
November 27, 2025
Market insights predict, the antitumor ADC drugs industry is expected to grow from USD 7.38 billion in 2025 to USD 24.75 billion by 2035, driven by a CAGR of 12.86%. Rising cancer incidence/unmet needs have driven the growth of the market. North Amer...
November 01, 2025
The generic drugs industry is expected to grow from USD 487.21 billion in 2024 to USD 816.75 billion by 2034, driven by a CAGR of 5.3%, driven by the need to reduce healthcare costs. North America leads the market, while Asia Pacific sees strong grow...
November 28, 2025
Projections indicate that, hyperkalemia drugs industry is projected to rise from USD 1.42 billion in 2025 to USD 5.20 billion by 2035, reflecting a CAGR of 13.84% over the next decade. The market is growing due to the rising prevalence of chronic kid...
October 15, 2025
According to market projections, the global anticancer drugs market, valued at USD 167.09 billion in 2024, is anticipated to reach USD 401.32 billion by 2034, growing at a CAGR of 9.14% over the next decade. The growing aging population is more susce...
November 01, 2025
The market is growing due to the rising prevalence of atopic diseases like dermatitis and asthma, coupled with increasing demand for advanced biologically targeted therapies. Growing awareness, better diagnostics, and expanding healthcare access are ...
November 20, 2025
Market insights predict the global cancer supportive care drugs industry will increase from USD 21.89 billion in 2024 to USD 27.05 billion by 2034, achieving a CAGR of 2.14%. The increased focus on the prevention and management of the adverse effects...
December 24, 2025
According to market projections, the GLP-1 drugs sector is expected to grow from USD 48.3 billion in 2024 to USD 121.13 billion by 2034, reflecting a CAGR of 9.63%. The GLP-1 drugs market is expanding due to increasing incidences of type 2 diabetes a...
November 05, 2025
Projections indicate that, the global anti-hypertensive drugs market will increase from USD 26.76 billion in 2025 to USD 39.2 billion by 2035, experiencing a CAGR of 3.89% over the next 10 years. Market growth is driven by the rising prevalence of hy...
October 24, 2025
Based on market forecasts, the biosynthesis peptide drugs sector will expand from USD 18.31 billion in 2024 to USD 32.88 billion by 2034, experiencing a CAGR of 6.26%. The biosynthesis peptide drugs market is growing, as these drugs offer many advant...
December 22, 2025
According to market projections, the diabetes drugs sector is expected to grow from USD 70.44 billion in 2024 to USD 134.73 billion by 2034, reflecting a CAGR of 6.7%. The diabetes drugs market is growing due to the rising global prevalence of diabet...
November 01, 2025
According to market projections, the hyperlipidemia drugs sector is expected to grow from USD 24.47 billion in 2025 to USD 31.49 billion by 2034, reflecting a CAGR of 2.84%. In 2024, North America led the global hyperlipidemia drugs market, with stat...
November 01, 2025
Based on market forecasts, the global gastrointestinal drugs market, projected at USD 40.21 billion in 2024, is expected to reach USD 55.85 billion by 2034, growing at a CAGR of 3.34% over the forecast period. The gastrointestinal drugs market is gro...
December 23, 2025
Projections indicate that, the global anti-obesity drugs market will increase from USD 7.17 billion in 2024 to USD 78.46 billion by 2034, experiencing a CAGR of 27.04% over the next 10 years. In 2024, North America led the anti-obesity drugs market, ...
November 01, 2025
According to market projections, the topical drugs CDMO sector is expected to grow from USD 46.32 billion in 2024 to USD 136.71 billion by 2034, reflecting a CAGR of 11.43%. In 2024, Asia Pacific led the topical drugs CDMO market, with Latin America ...
November 01, 2025
According to forecasts, the global respiratory drugs market will grow from USD 17.53 billion in 2024 to USD 30.81 billion by 2034, with an expected CAGR of 5.8%. In 2023, COPD was the most common respiratory disorder, leading the market with a 36% sh...
November 01, 2025
According to market projections, the global insulin drugs and delivery devices market, valued at USD 23.75 billion in 2024, is anticipated to reach USD 49.18 billion by 2034, growing at a CAGR of 7.65% over the next decade. The rising prevalence of d...
November 28, 2025
According to market projections, the global 3D printed drugs market, valued at USD 131.25 million in 2025, is anticipated to reach USD 547.36 million by 2035, growing at a CAGR of 15.35% over the next decade. In 2024, North America led the 3D printed...
December 22, 2025
According to forecasts, the global asthma and COPD drugs market will grow to USD 70.27 billion by 2035, with an expected CAGR of 5.01%. In 2024, King's College London showed that benralizumab can reduce hospitalizations in severe asthma and treat ast...
October 30, 2025
According to market projections, the global antipyretic and analgesic drugs market, valued at USD 47.47 billion in 2024, is anticipated to reach USD 77.99 billion by 2034, growing at a CAGR of 5.09% over the next decade. The rising prevalence of feve...
November 01, 2025
Market insights predict, the epilepsy drugs industry is expected to grow from USD 9.98 billion in 2024 to USD 16.42 billion by 2034, driven by a CAGR of 5.1%. Epilepsy drugs help control seizures by stabilizing brain activity. They work by reducing e...
November 01, 2025
According to forecasts, the global HIV drugs market size will grow from USD 34.75 billion in 2024 to USD 52.95 billion by 2034, with an expected CAGR of 4.3%. In 2023, combination-class drugs led the HIV drugs market with a 60% share, while hospital ...
November 01, 2025
Eltrombopag Drugs Market: In October 2024, Jiaheng (Zhuhai Hengqin) Pharmaceutical Technology Company Limited gained approval from China's National Medical Products Administration to market Eltrombopag Olamine tablets. Additionally, in November 2023,...
December 24, 2025
Projections indicate that, drugs industry is projected to rise from USD 1688.14 billion in 2025 to USD 3034.63 billion by 2035, reflecting a CAGR of 6.04% over the next decade. Around the world, an increasing geriatric patients with chronic condition...
October 24, 2025
The chemical synthesis peptide drugs market is valued at US$ 2.74 billion in 2025 and is projected to reach US$ 4.82 billion by 2034, growing at a CAGR of 6.54%. Key segments include synthesis methods (chemical, non-chemical), technologies (SPPS, LPP...
November 20, 2025
According to forecasts, the global cardiovascular drugs market will grow from USD 150.02 billion in 2024 to USD 213.36 billion by 2034, with an expected CAGR of 3.65%. The cardiovascular drugs market is expanding due to growing early diagnosis as wel...
November 01, 2025
AI in clinical trials for drugs market is growing due to its use in clinical research to monitor and improve medication adherence. This is particularly through the use of applications, such as facial, digital biomarkers, and vocal expression. AI redu...
November 01, 2025
The anesthesia drugs market size is calculated at $0.669 bn in 2025 is to hit $2.058 bn by 2034. The anesthesia drugs market is growing due to rising surgical procedures, advancements in anesthesia techniques, and increasing demand for outpatient sur...
December 22, 2025
Market insights predict the global rheumatoid arthritis drugs industry will increase from USD 18.69 billion in 2024 to USD 29.31 billion by 2034, achieving a CAGR of 4.6%. Rheumatoid arthritis (RA) drugs help reduce pain, swelling, and joint damage b...
November 01, 2025
According to market projections, the U.S. pain management drugs sector is expected to grow from USD 31.84 billion in 2024 to USD 44.92 billion by 2034, reflecting a CAGR of 3.64%. The U.S. pain management drugs market is growing due to rising cases o...
November 01, 2025
Projections indicate that, anti-inflammatory drugs industry is projected to rise from USD 122.32 billion in 2024 to USD 274.79 billion by 2034, reflecting a CAGR of 8.43% over the next decade. In 2024, North America led the anti-inflammatory drugs ma...
November 01, 2025
According to forecasts, the global antipsychotic drugs market will grow from USD 19.45 billion in 2024 to USD 41.21 billion by 2034, with an expected CAGR of 7.8%. Antipsychotic drugs help manage symptoms of mental health conditions like schizophreni...
November 01, 2025
According to market projections, the global liver cancer drugs market, valued at USD 3.05 billion in 2024, is anticipated to reach USD 11.5 billion by 2034, growing at a CAGR of 14.2% over the next decade. Liver cancer drugs are medicines used to tre...
November 17, 2025
Based on market forecasts, the global Non-steroidal anti-inflammatory drugs market, projected at USD 23.16 billion in 2025, is expected to reach USD 37.73 billion by 2035, growing at a CAGR of 5% over the forecast period. Arthritis dominated the NSAI...
November 01, 2025
The market is growing due to its ability to accelerate drug discovery and optimize personalized treatment strategies. This leads to faster development timelines, reduced costs, and improved patient outcomes....
November 01, 2025
The organ transplant immunosuppressant drugs market size is calculated at $5.81 bn in 2025 is to hit $8.82 bn by 2034. In 2024, Eledon Pharmaceuticals showed positive trial results for tegoprubart in islet transplant recipients with type 1 diabetes. ...
November 06, 2025
Market insights predict the global inhalation and nasal spray generic drugs industry will increase from USD 25.18 billion in 2025 to USD 59.35 billion by 2035, achieving a CAGR of 8.99%. The inhalation and nasal spray generic drugs market is expandin...
October 28, 2025
Based on market forecasts, the targeted drugs for allergic diseases sector will expand from USD 13.96 billion in 2024 to USD 30.22 billion by 2034, experiencing a CAGR of 8.06%. The targeted drugs for allergic diseases market is growing due to rising...
November 01, 2025
Market insights predict the global pediatric drugs industry will increase from USD 144.88 billion in 2024 to USD 458.09 billion by 2034, achieving a CAGR of 12.2%. Pediatric drugs are medicines specially designed for children to treat illnesses, mana...
November 27, 2025
According to market projections, the global sinusitis drugs market, valued at USD 2.33 billion in 2025, is anticipated to reach USD 4.16 billion by 2035, growing at a CAGR of 5.96% over the next decade. The growing research activities and increasing ...
November 01, 2025
According to market projections, the antimalarial drugs sector is expected to grow from USD 1.07 billion in 2024 to USD 1.67 billion by 2034, reflecting a CAGR of 4.57%. Establishing awareness and government programs are propelling the global market ...
December 23, 2025
According to market projections, the global over-the-counter or OTC drugs market, valued at USD 142.27 billion in 2025, is anticipated to reach USD 268.32 billion by 2035, growing at a CAGR of 6.55% over the next decade. In 2024, North America led th...
October 29, 2025
According to market projections, the global pulmonary arterial hypertension drugs market, valued at USD 8.04 billion in 2024, is anticipated to reach USD 12.38 billion by 2034, growing at a CAGR of 4.44% over the next decade. The market is growing du...
November 01, 2025
According to forecasts, the global age-related macular degeneration (AMD) drugs market will grow from USD 10.57 billion in 2024 to USD 29.04 billion by 2034, with an expected CAGR of 10.66%. Rising patient demand for a better quality of life is estim...
November 01, 2025
According to market projections, the pelvic inflammatory disease treatment sector is expected to grow from USD 3.52 billion in 2024 to USD 5.09 billion by 2034, reflecting a CAGR of 3.75%. In 2024, North America led the global pelvic inflammatory dis...
November 01, 2025
According to market estimations the global leuprorelin drugs market, valued at US$ 2.60 billion in 2023, is projected to reach US$ 4.78 billion by 2034, driven by rising cancer cases and gender-affirming surgeries. North America leads the market, w...
+1 9197 992 333
+91 93077 85324
sales@towardshealthcare.com